APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation

March 06, 2024 11:22 PM AEDT | By Cision

Google News:

APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation — Image source: Kalkine Media

Recent News

Global Times: Realizing high-quality development by eliminating 'rat r...

Wynn Macau and Wynn Palace Will Host Asia's 50 Best Bars 2025 Awards T...

SM: Enabling Resilient and Sustainable Development

Global Times: Grassroots organizations in China witness more participa...

SINGAPORE, March 6, 2024 /PRNewswire/ -- APAX Medical & Aesthetics Clinic is proud to announce the introduction of the ADVATx laser treatment by Advalight in their offerings - a revolutionary laser system that targets both active acne and acne scars simultaneously. This innovative solution utilises two laser wavelengths, offering a unique and comprehensive approach to dermatological care. Set to launch on 1 March 2024, the Advalight treatment is a game-changer for individuals seeking advanced and effective acne and acne scar removal treatment in Singapore.

The ADVATx laser treatment sets itself apart by addressing the dual challenge of active acne and acne scars in a single procedure. By targeting inflammation, sebaceous glands, and acne scars concurrently, this cutting-edge therapy provides a more holistic solution compared to traditional approaches. Not only does it excel in acne management, post acne redness, pigmentation and scarring, but it also extends its efficacy to treat conditions like rosacea, melasma, red or hypertrophic scars, and broken capillaries.

Acknowledging the challenges associated with acne relapse, APAX Medical & Aesthetics Clinic emphasises the importance of maintenance therapy with topical retinoids. Early intervention is crucial to preventing potential scarring and enhancing the overall quality of life for patients. The ADVATx laser treatment aligns with APAX Medical's commitment to comprehensive skincare, addressing challenges head-on to deliver optimal results.

Studies have found that acne scarring affects up to 95% of patients with acne, and is severe in 30% of cases, leading to long-term effects like poor self-esteem, anxiety, depression, and social impairment, emphasising the importance of treating active acne and acne scars concurrently to reduce disease burden and potential scarring. Recognising this need, ADVATx laser treatment is APAX Medical's latest addition to an impressive portfolio of services. APAX Medical's commitment to advancing skincare solutions, including treatment for cystic acne, acne scars, hormonal acne, back acne and more, is reflected in its history of delivering exceptional results and building a diverse client portfolio.

APAX Medical's unveiling of the ADVATx laser treatment marks a significant milestone in the management of acne and acne scars. With a rich history of excellence, APAX Medical & Aesthetics Clinic addresses acne comprehensively and aims to position itself as a leader in providing cutting-edge solutions for skincare.

For further information or inquiries, please visit https://apaxmedical.com/.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.